Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma?
Saved in:
| Title: | Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma? |
|---|---|
| Authors: | Obi S; Department of Internal Medicine, Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara, Chiba, 299-0111, Japan. obis@med.teikyo-u.ac.jp., Omata M; Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.; The University of Tokyo, Tokyo, Japan. |
| Source: | Hepatology international [Hepatol Int] 2026 Apr 19. Date of Electronic Publication: 2026 Apr 19. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42001382 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Obi+S%22">Obi S</searchLink>; Department of Internal Medicine, Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara, Chiba, 299-0111, Japan. obis@med.teikyo-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Omata+M%22">Omata M</searchLink>; Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.; The University of Tokyo, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101304009%22">Hepatology international</searchLink> [Hepatol Int] 2026 Apr 19. <i>Date of Electronic Publication: </i>2026 Apr 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101304009 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1936-0541 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219360533%22">19360533 </searchLink><i>NLM ISO Abbreviation: </i>Hepatol Int <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42001382 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12072-026-11089-1 Languages: – Code: eng Text: English Titles: – TitleFull: Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Obi S – PersonEntity: Name: NameFull: Omata M IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 04 Text: 2026 Apr 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1936-0541 Titles: – TitleFull: Hepatology international Type: main |
| ResultId | 1 |